Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Primis Financial Corp.FRST · Entity 1375 | EVP, Chief Risk Officer | March 08, 2022 | March 10, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Primis Financial Corp.
Report date March 08, 2022 · Filed March 10, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,254 |
Reported balance
After 2022-03-08 transaction · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · 2022-03-08 · Purchase · Acquired 1,754 · Balance 4,254 F1: Includes shares of restricted stock |
| Common StockSEC Table I · non-derivative | Direct | 6,000 |
Reported balance
Holding disclosure · report date 2022-03-08 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 6,000 F2: Reflects shares held in an IRA for Mr. Colantoni's benefit |
| Common StockSEC Table I · non-derivative | Direct | 816 |
Reported balance
Holding disclosure · report date 2022-03-08 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 816 F3: Reflects shares held jointly with son |
| Common StockSEC Table I · non-derivative | IndirectBy 401K Plan | 13,205 |
Reported balance
Holding disclosure · report date 2022-03-08 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 13,205 F4: Reflects total shares held in 401K plan |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.38 · Expires 2023-06-17 | Direct | 3,000 |
Reported balance
Holding disclosure · report date 2022-03-08 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 3,000 |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.47 · Expires 2024-07-22 | Direct | 4,500 |
Reported balance
Holding disclosure · report date 2022-03-08 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 4,500 |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.43 · Expires 2025-06-19 | Direct | 6,500 |
Reported balance
Holding disclosure · report date 2022-03-08 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 6,500 |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.99 · Expires 2026-06-17 | Direct | 8,500 |
Reported balance
Holding disclosure · report date 2022-03-08 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 8,500 |
Filing footnotes · ownership attribution and instrument terms
F1: Includes shares of restricted stock
F2: Reflects shares held in an IRA for Mr. Colantoni's benefit
F3: Reflects shares held jointly with son
F4: Reflects total shares held in 401K plan
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 08, 2022 Filed Mar 10, 2022 15:15 UTC | Primis Financial Corp. FRST · Entity 1375 | PurchaseCommon Stock | 1,754 | $13.79 | $24,187.66 |
DisclosureSEC source: 0001209191-22-017830 · doc4.xml · nonDerivative · entry 1 Colantoni Jr John · CIK 0001812381 · EVP, Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,254 F1 · balance_after: Includes shares of restricted stock Read SEC document |
| September 01, 2021 Filed Sep 2, 2021 19:42 UTC | Primis Financial Corp. FRST · Entity 1375 | GrantPerformance-based Restricted Stock Units · Derivative | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-054582 · doc4.xml · derivative · entry 5 Colantoni Jr John · CIK 0001812381 · EVP, Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 1,500 shares Expires 2026-03-15 F6 · derivative.exercise_price: Market value at date of vesting Read SEC document |
| September 01, 2021 Filed Sep 2, 2021 19:42 UTC | Primis Financial Corp. FRST · Entity 1375 | GrantCommon Stock | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-054582 · doc4.xml · nonDerivative · entry 1 Colantoni Jr John · CIK 0001812381 · EVP, Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 F1 · shares: Issued restricted stock which vest in five annual installments beginning March 1, 2022 F2 · balance_after: Includes shares of restricted stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.